Gonadotropin-releasing hormone agonist combined with recombinant human chorionic gonadotropin

This page covers all Gonadotropin-releasing hormone agonist combined with recombinant human chorionic gonadotropin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GnRH receptor (for GnRH-a component); LH/hCG receptor (for rhCG component), Gonadotropin-releasing hormone receptors, Gonadotropin-releasing hormone receptor.

Targets

GnRH receptor (for GnRH-a component); LH/hCG receptor (for rhCG component) · Gonadotropin-releasing hormone receptors · Gonadotropin-releasing hormone receptor

Marketed (2)

• Ovulation triggering with GnRH-a+rhCG · Fundación Santiago Dexeus Font · Reproductive Medicine / Fertility
  GnRH agonist priming followed by recombinant human chorionic gonadotropin (rhCG) triggers final oocyte maturation and ovulation in assisted reproductive technology cycles.
• Synarel · Pfizer Inc. · Oncology
  Gonadotropin-releasing hormone agonist medication

Phase 3 pipeline (1)

• releasing hormone agonist therapy · Cancer Research UK · Oncology
  Releasing hormone agonist therapy works by mimicking the action of natural hormones to stimulate the release of other hormones.